Wegovy Lawsuit [2024 Update]

Wegovy and Other Weight Loss Drugs Linked to Serious Side Effects

Glucagon-like peptide-1 receptor agonists (GLP-1 RA) were initially developed to manage type 2 diabetes by regulating blood sugar levels.

These medications, including Ozempic and Wegovy, have gained popularity for their off-label use to treat obesity and lose weight due to their ability to reduce appetite and slow gastric emptying.

Wegovy was specifically created as a weight loss drug, even though it contains the same active ingredient, semaglutide, as Ozempic.

The rise in popularity of these drugs is driven by its dramatic weight loss results, promoted extensively on social media and through use by celebrities.

Despite their popularity, GLP-1 diabetes drugs and weight loss drugs have been linked to severe gastrointestinal problems.

Drug manufacturers are now facing countless lawsuits from individuals who have developed stomach paralysis, severe abdominal pain, cyclic vomiting syndrome, and other serious health complications.

How Does Wegovy Help People Lose Weight?

Wegovy helps people lose weight by mimicking the GLP-1 hormone, which regulates appetite and food intake.

It works by slowing down stomach emptying, making individuals feel fuller for longer periods, thereby reducing overall food consumption.

Wegovy enhances insulin secretion and decreases glucagon levels, which helps manage blood sugar and reduces hunger.

How is Wegovy Dangerous?

Wegovy, a GLP-1 receptor agonist, is considered dangerous due to its association with severe gastrointestinal issues, such as gastroparesis, ileus, and bowel obstruction.

Scientific studies have shown that GLP-1 drugs caused a statistically significant number of patients to develop these severe side effects.

The slowing of gastric emptying, which helps in weight loss, can also lead to chronic nausea, vomiting, and abdominal pain.

The FDA has updated the warning labels for these drugs to include the risk of intestinal blockage.

Patients using Wegovy should be aware of these risks and monitor for any severe symptoms.

The growing number of adverse event reports and ongoing lawsuits highlight the serious health concerns associated with Wegovy and other GLP-1 drugs.

Health Problems Linked to Wegovy, Ozempic, and Other Similar Weight Loss Drugs

Wegovy and Ozempic, both GLP-1 receptor agonists, have been linked to severe gastrointestinal issues that significantly impact patients’ health.

Studies indicate these drugs can cause gastroparesis, where stomach paralysis leads to chronic nausea and vomiting.

As mentioned, the FDA now requires the drug manufacturers to include warnings about the risk of ileus, an intestinal blockage that can be life-threatening if not treated promptly.

These side effects are more prevalent than initially understood, with a significant number of patients reporting serious complications.

The risks associated with these diabetes and weight loss drugs necessitate careful consideration and monitoring.

Health problems associated with GLP-1 drugs like Wegovy include:

• Gastroparesis (stomach paralysis)
• Ileus (intestinal blockage)
• Severe nausea and vomiting
• Bowel obstruction
• Chronic abdominal pain
• Dehydration and malnutrition due to prolonged gastrointestinal issues
• Potential need for surgical intervention to address severe complications​

What is Severe Gastroparesis?

Gastroparesis is a medical condition characterized by the stomach’s inability to empty its contents properly due to impaired motility of the stomach muscles.

This condition can lead to severe symptoms such as chronic nausea, vomiting, abdominal pain, bloating, and significant weight loss.

Patients may also experience malnutrition and dehydration due to the stomach’s failure to move food efficiently into the intestines.

Gastroparesis can severely impact quality of life, making it difficult for patients to eat or maintain proper nutrition.

Treatment typically involves dietary changes, medications to stimulate stomach motility, and in severe cases, surgical interventions such as the placement of a feeding tube or gastric pacemaker​

The use of GLP-1 drugs like Ozempic and Wegovy has been linked to the development of severe gastroparesis.

These medications, while effective for weight loss and diabetes management, can slow gastric emptying, leading to this debilitating condition.

Patients using these drugs should be aware of the risks and monitor for symptoms of gastroparesis.

If you believe you are suffering from gastroparesis, it is essential to seek immediate medical attention.

Do You Qualify for the Wegovy Lawsuit?

Taking Ozempic or Wegovy puts individuals at a heightened risk for serious complications and potentially permanent injuries.

Lawsuits are now being filed on behalf of those who have developed severe gastroparesis and other serious injuries from taking Ozempic, Wegovy, and other GLP 1 RA medications.

If you were prescribed Wegovy or other semaglutide drugs and developed stomach paralysis, intestinal blockage, or other conditions affecting gastric emptying, you may be eligible to file a Wegovy Lawsuit.

Contact our lawyers today for a free consultation.

You can also use the chatbot on this page for a free case evaluation.

Lawyers will help their clients throughout the legal process, assisting them with gathering and retaining crucial evidence and assessing their damages.

Gathering Evidence for Wegovy Lawsuits

Evidence is the cornerstone of any successful personal injury lawsuit.

It is essential that patients who have used these drugs retain any related medical documentation and further evidence to support their claims.

This is a part of the legal process you can begin on your own, but an experience lawyer will help you gather and retain evidence.

Possible evidence in a Wegovy Lawsuit may include:

• Medical records: Documentation of diagnoses and treatments related to side effects.
• Prescription records: Evidence of Wegovy prescriptions and dosages.
• Diagnostic tests: Results of tests such as gastric emptying studies or endoscopies.
• Symptom diaries: Patient records detailing the onset and progression of symptoms.
• Expert testimony: Statements from medical professionals linking Wegovy use to health issues.
• Adverse event reports: Filed with the FDA or other regulatory bodies.
• Correspondence: Communications with healthcare providers regarding side effects.
• Product information: Labels, warnings, and marketing materials provided by Novo Nordisk.
• Research studies: Scientific literature and studies showing the risks associated with GLP-1 drugs.
• Witness statements: Testimonies from family members or caregivers about the impact on daily life.

This evidence can help build a strong case by demonstrating the direct connection between Wegovy use and the adverse health outcomes experienced by the patient​

Damages in Wegovy Lawsuits

Damages refer to the total amount of losses incurred as a result of using Wegovy and the development of related medical conditions.

Your lawyer will help you to assess and calculate damages.

Possible damages in a Wegovy Lawsuit may include:

• Medical bills: Costs incurred for initial and ongoing treatments related to side effects.
• Future medical expenses: Anticipated costs for long-term medical care and treatments.
• Emotional distress: Psychological impact of the health issues and their treatment.
• Pain and suffering: Compensation for physical pain and discomfort experienced.
• Lost wages: Income lost due to inability to work while undergoing treatment.
• Loss of earning capacity: Reduction in future earning potential due to health complications.
• Loss of enjoyment of life: Impact on the ability to participate in and enjoy daily activities.

Is There an Ozempic and Wegovy Class Action Lawsuit?

No, there is not a class action lawsuit for injuries and health problems associated with the use of Ozempic and Wegovy or other weight loss drugs.

Lawsuits for both Ozempic and Wegovy, as well as other semaglutide drugs, are being consolidated into a single federal court under a process known as multidistrict litigation (MDL).

The Judicial Panel on Multidistrict Litigation (JPML) certified the establishment of the Glucagon-like Peptide-1 Receptor Agonists (GLP-1 RAS) Products Liability Litigation (MDL 3094) in the US District Court for the Eastern District of Pennsylvania.

MDL and class action are separate and distinct legal processes.

The litigation provides an avenue for those with Wegovy and Ozempic Lawsuits to seek compensation in an organized and unified manner.

Within an MDL, your case remains individual and in the event of a settlement, a successful claim would be compensated according to the unique facts and circumstances of the case.

This is different from class action lawsuits, where claims are combined together into one legal action and the compensation is evenly distributed among all plaintiffs regardless of their individual circumstances.

What Drug Manufacturers are Named in the Ozempic and Wegovy Lawsuits?

The lawsuits concerning Ozempic and Wegovy primarily name Novo Nordisk, the manufacturer of both drugs, as the defendant.

Eli Lilly, the manufacturer of another GLP-1 drug called Mounjaro, is also named in related litigation due to similar adverse effects reported from their medication.

These lawsuits allege that the manufacturers failed to provide adequate warnings about the severe gastrointestinal risks associated with these drugs.

Named Drug Manufacturers:

• Novo Nordisk: Manufacturer of Ozempic and Wegovy
• Eli Lilly: Manufacturer of Mounjaro

These manufacturers are being sued for claims that their medications cause serious health issues like gastroparesis and ileus, impacting numerous patients who used the drugs for weight loss and diabetes management​.

TorHoerman Law: Lawyers for the Wegovy and Ozempic Lawsuit

Ozempic and Wegovy’s side effects can severely impact a person’s health and quality of life by causing chronic pain, digestive issues, and the inability to perform daily activities.

Lawsuits are being filed on behalf of patients who have suffered from these severe side effects, alleging that the manufacturers failed to adequately warn users about the risks.

It is the manufacturer’s responsibility to ensure the safety and efficacy of their medications, providing clear warnings about potential side effects to protect patients’ health and well-being​.

If you or a loved one have suffered from severe gastroparesis, bowel obstruction, or other health problems after taking Wegovy or other similar drugs, you may be eligible to file an Wegovy Lawsuit.

Contact the Wegovy Lawyers at TorHoerman Law for a free consultation.

You can also use the chatbot on this page for a free case review to find out if you qualify to file a Wegovy Lawsuit instantly.

Our attorneys recognize the devastating impact that Wegovy-related health issues can have on your daily life.

We are sensitive to the needs of our clients and will do everything in our power to seek justice and compensation on your behalf.

Reach out to us today for more information.

We’re here to help you.